ACS

Featured Article

Cardiovascular Complications of COPD

Cardiovascular Complications of COPD

A 55-year-old man with chronic obstructive pulmonary disease reports having some mild chest pain.

Latest Features

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Hospitals may be missing opportunities to start tobacco use treatment immediately after myocardial infarction.

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Evidence is lacking to support oxygen therapy for acute myocardial infarction.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Poor adherence to dual antiplatelet therapy plays a significant role in outcomes for patients with acute coronary syndromes.

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

The American Association of Clinical Endocrinologists site lack of evidence of cardiovascular disease risk in testosterone therapy use.

Latest News

NSTEMI Risk for ICU Complications Predicted Using ACTION ICU Risk Score

NSTEMI Risk for ICU Complications Predicted Using ACTION ICU Risk Score

When patient risk was predicted using ACTION ICU model, the likelihood of a complication developing that required ICU care increased >10-fold from the lowest to the highest scores.

Aldosterone Antagonists Improved Survival in STEMI Without Heart Failure

Aldosterone Antagonists Improved Survival in STEMI Without Heart Failure

Aldosterone antagonists significantly reduced the risk for mortality in patients with ST-segment elevation myocardial infarction without heart failure.

Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes

Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes

Investigators examined the time to first event composing of cardiovascular death, myocardial infarction, or stroke.

CV Risks With Alogliptin in Type 2 Diabetes and Recent Acute Coronary Syndrome

CV Risks With Alogliptin in Type 2 Diabetes and Recent Acute Coronary Syndrome

Investigators conducted a randomized, double-blinded, placebo-trolled trial in patients with T2D after an acute coronary syndrome.

Liraglutide May Affect Clinical Outcomes of Myocardial Infarction in Type 2 Diabetes

Liraglutide May Affect Clinical Outcomes of Myocardial Infarction in Type 2 Diabetes

Liraglutide may reduce the incidence of myocardial infarction in patients who have a high cardiovascular risk with type 2 diabetes.

Oxygen Therapy in Acute MI Not Associated With Clinical Benefit

Oxygen Therapy in Acute MI Not Associated With Clinical Benefit

Patients with confirmed or suspected acute myocardial infarction do not benefit from supplemental oxygen therapy.

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Women are less likely than men to fill a high-intensity statin prescription following hospitalization for myocardial infarction.

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Although varenicline was effective for short-term smoking cessation, more than half of the patients in the EVITA trial relapsed after 1 year.

Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain

Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain

Two analyses were conducted, one during the training phase and the second during the validation phase of the study.